Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4Hquinazolin-3-yl)-piperidine-2,6-dione

US8906932B2 · kind B2 · utility

Assignee

• CELGENE CORPORATION · US

Inventors

• George W. Muller · Northbrook, US
• Peter Schafer · Ottersheim, DE
• Hon-Wah Man · Princeton, US
• Ling-Hua Zhang · Mountain Lakes, US
• Anita Gandhi · Bernardsville, US
• Rajesh Chopra · San Ramon, US

Key dates

• Filing date: Mar 9, 2012
• Grant date: Dec 9, 2014
• Expiry date: Mar 9, 2032

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2300/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are methods of treating, preventing and/or managing cancers, which comprise administering to a patient 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof.